Skip to main content
Journal of Clinical Biochemistry and Nutrition logoLink to Journal of Clinical Biochemistry and Nutrition
. 2016 Apr 29;59(1):65–70. doi: 10.3164/jcbn.15-152

Comparison of the gut microbial community between obese and lean peoples using 16S gene sequencing in a Japanese population

Akira Andoh 1,*, Atsushi Nishida 1, Kenichiro Takahashi 1, Osamu Inatomi 1, Hirotsugu Imaeda 1, Shigeki Bamba 1, Katsuyuki Kito 1, Mitsushige Sugimoto 1, Toshio Kobayashi 2
PMCID: PMC4933688  PMID: 27499582

Abstract

Altered gut microbial ecology contributes to the development of metabolic diseases including obesity. In this study, we performed 16S rRNA sequence analysis of the gut microbiota profiles of obese and lean Japanese populations. The V3–V4 hypervariable regions of 16S rRNA of fecal samples from 10 obese and 10 lean volunteers were sequenced using the Illumina MiSeqTMII system. The average body mass index of the obese and lean group were 38.1 and 16.6 kg/m2, respectively (p<0.01). The Shannon diversity index was significantly higher in the lean group than in the obese group (p<0.01). The phyla Firmicutes and Fusobacteria were significantly more abundant in obese people than in lean people. The abundance of the phylum Bacteroidetes and the Bacteroidetes/Firmicutes ratio were not different between the obese and lean groups. The genera Alistipes, Anaerococcus, Corpococcus, Fusobacterium and Parvimonas increased significantly in obese people, and the genera Bacteroides, Desulfovibrio, Faecalibacterium, Lachnoanaerobaculum and Olsenella increased significantly in lean people. Bacteria species possessing anti-inflammatory properties, such as Faecalibacterium prausnitzii, increased significantly in lean people, but bacteria species possessing pro-inflammatory properties increased in obese people. Obesity-associated gut microbiota in the Japanese population was different from that in Western people.

Keywords: 16S sequence, datamining, Firmicutes, Bacteroides, SCFA

Introduction

Obesity is one of the most serious public health concerns worldwide.(1,2) More than 500 million people are obese, and its prevalence is dramatically increasing not only in developed countries but also in developing countries.(1,3) Obesity is associated with a higher risk for health problems such as heart disease, stroke, high blood pressure, diabetes mellitus and more.(1) A worldwide study in 2010 reported that obesity is associated with 3–4 million deaths, 4% of years of life lost, and 4% of disability-adjusted life-years lost.(4)

The effect of the gut microbiota on human health is recognized as a mutually beneficial interaction between human and indigenous microorganisms that contributes to normal physiology and immune homeostasis.(5) The gut microbiota regulates metabolic function and energy balance, and an altered microbial ecology contributes to the development of several metabolic diseases including obesity. For example, the gut microbiota profile of obese people is characterized by a reduced proportion of the phylum Bacteroidetes and an increased proportion of the phylum Firmicutes, compared to lean people.(6) These changes are considered to affect the metabolic potential of the gut microbiota and enhance the body’s capacity to harvest energy from the diet.(7) Transfer of the gut microbiota from obese mice leads to a significantly greater accumulation of adipose tissue in recipient mice than a transfer of the gut microbiota from lean donors.(8) Thus, the gut microbiota is a critical environmental factor contributing to the development of obesity.

In previous studies, alteration of the gut microbiota in obese people has been studied mainly in Western countries.(3,6,7,9) De Filippo et al.(10) previously demonstrated a difference in the gut microbial structure between obese European children and lean African children, indicating that environmental factors such as diet, sanitation and hygiene are important for shaping the gut microbiota. This leads to the possibility that obesity-associated gut microbiota might be different between Western and Asian populations, since lifestyles including dietary habits are quite different. However, alteration of the gut microbiota profile has not been extensively investigated in Asian people in general or in the Japanese population in particular. Therefore, it is important to investigate the obesity-associated gut microbiota profile of Japanese people.

In the present study, we performed 16S rRNA sequence analysis of the gut microbiota profile in 10 obese and 10 lean Japanese people. Furthermore, bacterial species that contributed to the difference in the gut microbiota composition between obese and lean people were characterized.

Materials and Methods

Subjects and setting

Twenty volunteers (10 obese people and 10 lean people) were enrolled in this study. The body mass index (BMI) of the obese people was 38.1 ± 3.5 kg/m2 (mean ± SD) (range 35.7–49.2 kg/m2) and the BMI of the lean people was 16.6 ± 1.0 kg/m2 (range 14.2–17.7 kg/m2) (Table 1). No one was receiving medical treatment, drugs or supplements that could potentially modulate the gut microbiota. The Institutional Review Board of the Shiga University of Medical Science approved the study, and written informed consent was obtained from each person prior to enrolment.

Table 1.

Backgrounds of volunteers enrolled in this study

Obese Lean p value
Gender (female/male) 5/5 5/5
Age [mean (range)] 41 (35–55) 45 (31–58)
Body weight (kg, mean ± SD) 101.1 ± 13.6 42.5 ± 4.1 <0.01
Height (cm, mean ± SD) 162.9 ± 9.0 159.8 ± 6.1 0.22
Body mass index (mean ± SD) 38.1 ± 3.5 16.6 ± 1.0 <0.01
Fasting blood sugar (mg/dl) 107.0 ± 34.7 85.8 ± 7.1 <0.05
Total chelesterol (mg/dl) 222.2 ± 26.6 216.6 ± 33.4 0.56
triglyceride (mg/dl) 136.5 ± 53.8 65.1 ± 35.7 <0.01

DNA extraction

DNA was extracted from fecal samples according to a previously described method.(11) The fecal samples were suspended in a buffer containing 4 M guanidium thiocyanate, 100 mM Tris-HCl (pH 9.0) and 40 mM EDTA and beaten in the presence of zirconia beads using the FastPrep FP100A Instrument (MP Biomedicals, Irvine, CA). Thereafter, the DNA was extracted from the beads-treated suspension using a Magtration System 12GC and GC series Magtration–MagaZorb DNA Common Kit 200 N (Precision System Science, Chiba, Japan). The final concentration of DNA sample was adjusted to 10 ng/µl.

16S rRNA sequencing

16S rRNA sequencing using the MiSeqTMII system (Illumina, San Diego, CA) was performed according to a previously described method.(12) The V3–V4 hypervariable regions of 16S rRNA were PCR amplified from microbial genomic DNA using the following universal primers: 341F, 5'-AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTCCTACGGGAGGCAGCAGCCTACGGGAGGCAGCAG-3';(12) 806R, 5'-CAAGCAGAAGACGGCATAGAGATNNNNNNGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTGGACTACHVGGGTWTCTAAT-3'.(12) PCR products were purified through a MultiScreen PCR filter plate (Merck Millipore, Darmstadt, Germany). Barcoded V3 and V4 amplicons were sequenced using the paired-end, 2 × 250-bp cycle run on the MiSeqTMII system with MiSeq Reagent Kit ver. 2 (500 Cycle) chemistry. The resulting sequences were then screened and filtered for quality and length. Paired-end sequencing with read lengths of 251 bp was joined together with the fastq-join program (http://code.google.com/p/ea-utils/). Only reads that had quality value (QV) scores of ≥20 for more than 99% of the sequence were extracted for further analysis. The nucleotide sequence dataset was deposited in the Sequence Read Archive of the DNA Data Bank of Japan (DDBJ) under the accession number DRA002295.

Principal component analysis and data mining

Principal component analysis (PCA) was performed using Metagenome@KIN (World Fusion, Tokyo, Japan). Data mining analysis was performed using SPSS Clementine14 software (IBM Japan, Tokyo, Japan). A dividing system using the Classification and Regression Tree (C&RT) approach, which is the most typical method for constructing decision trees, using the Gini coefficient(13) between obese (or lean) and operational taxonomic unit (OTU) data of the order level was applied. The records were divided into two subsets so that the records within each subset were more homogeneous than in the previous subset.

16S rDNA-based taxonomic analysis and statistical analysis

Analyses of sequence reads were performed using the Ribosomal Database Project (RDP) Multiclassifier tool (http://rdp.cme.msu.edu/classifier/)(14) and BLAST search using the Metagenome@KIN analysis software (World Fusion) for TechnoSuruga Lab Microbial Identification Database DB-BA9.0 (Technosuruga laboratory, Shizuoka, Japan). Reads showing ≥97% homology were grouped in each taxonomic rank. To evaluate the strength of influence of bacterial species, the LogWorth statistic for partition models was calculated using JMP8 statistical software (SAS Institute, Cary, NC). Differences between different samples were checked for statistical significance (p<0.05) using the Student’s t-tests. The data were analyzed using Statview 5.0 software (SAS).

Results

The baseline characteristics of the 20 subjects are shown in Table 1. Average body mass index (BMI) of the obese group (38.1 ± 3.5 kg/m2) was significantly higher than that of the lean group (16.6 ± 1.0 kg/m2) (p<0.01). Fasting blood sugar and triglyceride levels were also significantly higher in the obese group than in the lean group.

Initially, we performed 16S rRNA sequencing of the fecal samples from the obese and lean groups. The average of 20,486 reads per obese sample was significantly higher than the average of 17,358 reads per lean sample (Fig. 1A). In contrast, the Shannon diversity index (H’) was significantly higher in the lean group than in the obese group (Fig. 1B). These results indicate that the fecal microbial structure of lean people is more complex as compared to that of obese people.

Fig. 1.

Fig. 1

Results of 16S rRNA sequencing of fecal samples from obese (n = 10) and lean people (n = 10). (A) The average read number. The average number of reads per obese person was significantly higher than the average number of reads per lean person. (**p<0.01). (B) Shannon diversity index. The average of the Shannon diversity index was significantly higher in lean people than in obese people (**p<0.01). Data is expressed as mean ± SD (n = 10).

Based on the RDP database, all sequences were classified from the phylum to species. At the phylum level, Firmicutes, Bacteroidetes, Proteobacteria, and Actinobacteria were dominant in both the obese and lean groups. The phyla Firmicutes and Fusobacteria were significantly more abundant in the obese group than in the lean group (Firmicutes: 42.6 ± 8.5% in obese vs 35.1 ± 5.2% in lean, p = 0.018) (Fig. 2). In particular, the phylum Fusobacterium was detected only in obese people (1.86 ± 4.20% in obese vs 0.00 ± 0.00% in lean, p = 0.002). Previous studies demonstrated an increase of the phylum Bacteroidetes in lean people compared to obese people,(6) but we could not detect such a difference in our samples (31.2 ± 14.1% in obese vs 32.9 ± 6.4% in lean, p = 0.38). Furthermore, there was no significant difference in the Bacteroidetes/Firmicutes ratio between obese (0.86 ± 0.63) and lean people (0.96 ± 0.27).

Fig. 2.

Fig. 2

The gut microbial composition of obese and lean people (phylum level). *p<0.05, **p<0.01.

Principal component analysis (PCA) at the phylum level showed different distribution of obese and lean peoples (Fig. 3), suggesting a presence of potential difference between obese and lean microbial structure. Data mining was used to create a decision tree, which is a decision-supporting pathway (Fig. 4). Node 0 (the starting point for tree construction) was divided into Node 1 and Node 2 by the read number of the order Clostridiales with a cutoff value of 5617. Six of the 10 obese people were selectively allocated to Node 2 (Clostridiales read number ˃5,617), and 10 lean people and 4 obese people were allocated to Node 1 (Clostridiales read number ≤5,617). Node 1 was further sub-divided into Nodes 3, 5 and 6. All lean people were allocated to Node 6, which was characterized by a read number for the order Bacteroidales >2,667. These results suggest that at the order level, the microbial community of obese people is characterized by higher Clostridiales and that of lean people is characterized by higher Bacteroidales.

Fig. 3.

Fig. 3

Principal component analysis (PCA) at the phylum level between obese and lean peoples. PCA based on PC1 (proportion of contribution 59.3%) and of PC2 (proportion of contribution 23.1%) showed different distribution of obese and lean peoples.

Fig. 4.

Fig. 4

Decision tree constructed using the Classification and Regression Tree (C&RT) approach. The cutoff value to create each node was calculated from the read number of sequence data at the order level, using the Gini coefficient and the C&RT method. Similar steps were repeated to construct the decision tree. Node 0 is the starting point for tree construction, and the terminal node is one that cannot be further divided. The details related to the pathway leading to the terminal node clearly indicate the orders involved and their relative quantities, which contribute to creating the subject groups.

At the genus level, the obtained sequences were assigned to 105 genera, and these were numerically dominated by Bacteroides, Blautia, Bifidobacterium, Eubacterium, Faecalibacterium, Prevotella and Veillonella (Table 2). The genera Alistipes, Anaerococcus, Corpococcus, Fusobacterium and Parvimonas significantly increased in obese people as compared to lean people. In contrast, the genera Bacteroides, Desulfovibrio, Faecalibacterium, Lachnoanaerobaculum and Olsenella significantly increased in lean people compared to obese people.

Table 2.

Difference in bacterial composition between obese and lean peoples (Genus level)

Genus Obese (%) Lean (%) p value
Increased in obese peoples
Alistipes 2.20 0.50 0.04
Anaerococcus 0.01 0.00 0.01
Barnesiella 10.24 7.81 0.10
Butyricimonas 0.01 0.00 0.10
Campylobacter 0.05 0.00 0.08
Coprococcus 0.03 0.28 0.03
Delftia 1.34 0.74 0.10
Eubacterium 1.86 0.00 0.10
Fusobacterium 0.01 0.00 0.03
Holdemania 0.03 0.00 0.10
Parvimonas 0.01 0.00 0.01
Raoultella 0.01 0.00 0.09
Shigella 0.00 0.00 0.06
Solobacterium 0.54 1.26 0.06
Turicibacter 2.54 0.50 0.09
Increased in lean peoples
Allisonella 0.00 0.02 0.08
Bacteroides 0.08 0.20 0.05
 Bifidobacterium 0.00 0.01 0.11
 Collinsella 0.00 0.00 0.09
Coprobacillus 0.00 0.00 0.08
Corynebacterium 0.03 0.34 0.06
Desulfovibrio 0.02 0.10 0.05
Enterococcus 3.93 5.94 0.10
Faecalibacterium 0.00 0.02 0.04
Finegoldia 0.00 0.10 0.03
Howardella 0.00 0.00 0.10
Lachnoanaerobaculum 0.00 0.02 0.05
Olsenella 0.34 1.15 0.03
Subdoligranulum 0.00 0.00 0.04
Sutterella 16.90 22.50 0.10
Veillonella 0.03 0.00 0.09

At the species level, the obtained sequences were assigned to 345 species. Table 3 shows bacteria species that significantly increased in obese people compared to lean people. These included Acidaminococcus intestini, Actinomyces meyeri, Atopobium parvulum, Bacteroides vulgatus, Eubacterium hadrum, Klebsiella pneumoniae and Roseburia faecis. The genus Fusobacterium (F.) including Faecalibacterium (F.) mortiferum, F. nucleatum, and F. varium increased in obese people, but the difference was not significant.

Table 3.

Increased bacteria species in obese peoples

Species Obese (%) Lean (%) p value
Acidaminococcus intestini 1.851 0.102 0.013
Actinomyces meyeri 0.018 0.009 0.039
Atopobium parvulum 0.006 0.001 0.022
Bacteroides coprophilus 0.137 0.002 0.099
Bacteroides finegoldii 0.282 0.044 0.076
Bacteroides ovatus 1.886 0.546 0.097
Bacteroides vulgatus 10.586 2.456 0.023
Blautia wexlerae 5.589 3.798 0.086
Clostridium butyricum 0.005 0.000 0.172
Clostridium difficile 0.007 0.000 0.130
Clostridium nexile 0.171 0.006 0.081
Coprococcus comes 0.635 0.225 0.065
Eubacterium hadrum 2.157 0.438 0.050
Eubacterium infirmum 0.001 0.000 0.086
Fusobacterium mortiferum 1.376 0.002 0.107
Fusobacterium nucleatum 0.008 0.000 0.093
Fusobacterium varium 0.047 0.001 0.157
Gemella haemolysans 0.008 0.001 0.020
Granulicatella adiacens 0.012 0.005 0.023
Klebsiella pneumoniae subsp. 0.076 0.003 0.042
Lactococcus garvieae 0.000 0.004 0.088
Peptostreptococcus stomatis 0.007 0.000 0.007
Pseudomonas koreensis 0.001 0.000 0.084
Roseburia faecis 0.881 0.324 0.026
Rothia mucilaginosa 0.007 0.001 0.049
Ruminococcus gnavus 1.747 0.544 0.083

Table 4 shows the bacteria species that increased in lean people as compared to obese people. Clostridium ramosum, Clostridium citroniae, Faecalibacterium prausnitzii, Eubacterium desmolans, Eubacterium fissicatena, and Holdemania filiformis significantly increased in lean people compared to obese people (p<0.05). Bilophila wadsworthia tended to increase in lean people, but the difference was not significant.

Table 4.

Increased bacteria species in lean peoples

Species Obese (%) Lean (%) p value
Clostridium ramosum 0.002 0.008 0.042
Ruminococcus torques 0.230 0.685 0.058
Acetivibrio ethanolgignens 0.000 0.014 0.061
Anaerotruncus colihominis 0.000 0.022 0.089
Bacteroides dorei 1.987 5.673 0.086
Bacteroides stercorirosoris 0.000 0.018 0.089
Bilophila wadsworthia 0.078 0.202 0.051
Christensenella minuta 0.000 0.003 0.070
Clostridium citroniae 0.002 0.008 0.019
Clostridium xylanolyticum 0.046 0.208 0.054
Desulfovibrio piger 0.026 0.276 0.037
Dialister succinatiphilus 0.000 0.276 0.084
Eggerthella lenta 0.016 0.102 0.057
Eubacterium callanderi 0.000 0.066 0.094
Eubacterium coprostanoligenes 0.004 0.157 0.101
Eubacterium desmolans 0.002 0.103 0.029
Eubacterium fissicatena 0.004 0.016 0.038
Eubacterium ruminantium 0.002 0.189 0.061
Faecalibacterium prausnitzii 3.932 5.943 0.050
Flavonifractor plautii 0.069 0.152 0.067
Gordonibacter pamelaeae 0.001 0.011 0.041
Holdemania filiformis 0.000 0.003 0.034
Lactococcus lactis 0.004 0.020 0.088
Lactococcus garvieae 0.000 0.004 0.088
Parabacteroides distasonis 0.001 0.007 0.054
Roseburia hominis 0.006 0.099 0.061
Streptococcus intermedius 0.001 0.004 0.086
Subdoligranulum variabile 0.544 1.261 0.056

Discussion

In this study, we analyzed the fecal microbial community of obese and lean people in the Japanese population. Japan is an island nation and Japanese people are a single ethnic group. In addition, a distinctive food culture developed and has been maintained in this country. Therefore, a unique gut microbial community in the Japanese population is expected. Indeed, Nakayama et al.(15) recently reported a specific fecal microbial community in Japanese children that consists of more Bifidobacterium and fewer potentially pathogenic bacteria compared to the microbial communities of children in other Asian countries. Previous studies of obesity-associated gut microbiota mainly targeted people living in Western countries, but extensive studies have not been performed on the Japanese population. To understand the influence of certain dietary habits and ethnicity on the gut microbial composition, it would be valuable to characterize the obesity- and lean-associated gut microbial communities of the Japanese population.

In this study, we demonstrated that the microbial community of obese Japanese people was characterized by a reduced diversity and an increased abundance of the phyla Firmicutes and Fusobacteria as compared to that of lean people. A reduced diversity and an increased abundance of the phylum Firmicutes in obese people were consistent with previous studies in Western populations.(6,16,17) On the other hand, significance of the phylum Bacteroidetes in the obesity-associated gut microbiota remains to be discussed. Several studies confirmed a decrease of the phylum Bacteroidetes in obese individuals and animal models,(7,1821) but others did not report any difference between obese and lean subjects or even found the opposite relationship.(22,23) In this study, we could not detect a significant difference in the phylum Bacteroidetes. So, we further investigated the microbial structure at the order level using data mining analysis. Data mining was used to create a decision tree, as shown in Fig. 3, which clearly categorized the obese and lean people. Six of the 10 obese people were allocated to Node 2, which is characterized by a higher abundance of the order Clostridiales. In contrast, all of the lean people were allocated to Node 6, which is characterized by a higher abundance of the order Bacteroidales. Thus, the dominance of the order Bacteroidales in lean Japanese people became clear, although there were no definitive findings at the phylum level.

Short-chain fatty acids (SCFAs: acetate, propionate and butyrate) are generated through the fermentation of dietary fiber by the gut microbiota.(24) The bacterial SCFAs provide 10% of the total dietary energy supply in humans,(24) and fecal SCFA levels increase significantly in obese people compared to lean people.(22) Both the phyla Firmicutes and Bacteroidetes contribute to SCFA generation. It is known that alteration of the gut microbial composition affects changes in SCFA concentration,(25) and a higher Firmicutes/Bacteroidetes ratio is associated with obesity via increased generation of SCFAs.(7,18,19) In this study, however, we did not detect a significant difference in the Firmicutes/Bacteroides ratio between obese and lean people, although a higher proportion of the phylum Firmicutes was confirmed in obese people. Similar negative results have been reported previously,(22,23) and Murphy et al.(26) reported that changes in the proportions of the major phyla were unrelated to SCFA concentrations and energy harvest. These results suggest that the linkage between gut microbial composition, SCFA-related energy harvest and obesity may be complex and require further extensive investigations in the future.

A novel finding in this study was an increased abundance of the phylum Fusobacteria in obese people. This finding was also confirmed at the genus and species levels. The levels of F. infirmum, F. nucleatum and F. varium were higher in obese people than in lean people, although the difference was not significant. The phylum Fusobacteria induces host inflammatory response and possesses virulence characteristics that promote their adhesiveness to host epithelial cells and their ability to invade into epithelial cells.(27) Recent studies focused on the association of the phylum Fusobacteria with colorectal cancer,(27,28) and F. nucleatum has been shown to potentiate intestinal tumorigenesis by modulating β-catenin signaling.(28) F. varium has also been reported to be associated with the pathophysiology of ulcerative colitis.(29) However, the association between the phylum Fusobacteria and obesity has not been described previously. Our results do not imply a causal relationship between the phylum Fusobacteria and obesity, but suggest that the obesity-associated gut microbial community of the Japanese population may have a different composition compared to that of Western people. The exact role of the phylum Fusobacteria in obesity should be investigated in the future.

One of the mechanisms by which the intestinal microbiota affects obesity is the induction of systemic low-grade inflammation.(30) The gut microbiota increases mucosal permeability in obese mice, thereby promoting translocation of bacterial products (e.g., lipopolysaccharide) and stimulating the low-grade inflammation that is characteristic for obesity.(30) So, bacterial species abundantly present in the lean microbiota with anti-inflammatory properties may have a protective effect on obesity. One of such bacteria species, Faecalibacterium (F.) prausnitzii has strong anti-inflammatory activities via butyrate production and the induction of regulatory T cells,(3133) and has been reported to negatively correlate with inflammatory markers in obese subjects.(34,35) In this study, we actually observed a significant increase in the abundance of F. prausnitzii in lean peoples as compared to obese peoples. These results suggest that F. prausnitzii may play a protective role against obesity via its anti-inflammatory actions. In contrast, we observed that the abundance of the phylum Fusobacteria and Bacteroides (B.) vulgatus increased significantly in obese peoples as compare to lean peoples. The phylum Fusobacteria and B. vulgatus might play a causative role for obesity, since previous studies have reported the proinflammatory properties of these bacteria(27,36) and a positive correlation between the abundance of B. vulgatus and BMI.(37) Thus, it is likely that the balance of inflammatory and anti-inflammatory bacteria may be one of factors affecting the development of obesity.

In conclusion, we found that obesity-associated gut microbiota of Japanese people is somewhat different from that of Western people. In Japanese people, a decrease of the phylum Bacteroidetes and a decrease in the Firmicutes/Bacterodetes ratio were not detected. We found an increase of the phylum Fusobacteria in obese people for the first time. The differences between the Japanese population and Western populations could be caused by a variety of factors (e.g., dietary habits, hygiene and genetics).

Acknowledgments

Authors appreciate technical supports of TechnoSuruga Laboratory Co., Ltd. (Sizuoka, Japan) and would like to express thanks. This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (15K08967), a grant for the Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan, and a grant from Smoking Research Foundation. This study was partially supported by MSD Co., Ltd. (Tokyo, Japan).

Conflict of Interests

No potential conflicts of interest were disclosed.

References

  • 1.Kassebaum NJ, Bertozzi-Villa A, Coggeshall MS, et al. Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:980–1004. doi: 10.1016/S0140-6736(14)60696-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Stevens GA, Singh GM, Lu Y, et al. National, regional, and global trends in adult overweight and obesity prevalences. Popul Health Metr. 2012;10:22. doi: 10.1186/1478-7954-10-22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Nieuwdorp M, Gilijamse PW, Pai N, Kaplan LM. Role of the microbiome in energy regulation and metabolism. Gastroenterology. 2014;146:1525–1533. doi: 10.1053/j.gastro.2014.02.008. [DOI] [PubMed] [Google Scholar]
  • 4.Lim SS, Vos T, Flaxman AD, Danaei G, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224–2260. doi: 10.1016/S0140-6736(12)61766-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Rautava S, Luoto R, Salminen S, Isolauri E. Microbial contact during pregnancy, intestinal colonization and human disease. Nat Rev Gastroenterol Hepatol. 2012;9:565–576. doi: 10.1038/nrgastro.2012.144. [DOI] [PubMed] [Google Scholar]
  • 6.Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444:1022–1023. doi: 10.1038/4441022a. [DOI] [PubMed] [Google Scholar]
  • 7.Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027–1031. doi: 10.1038/nature05414. [DOI] [PubMed] [Google Scholar]
  • 8.Bäckhed F, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A. 2007;104:979–984. doi: 10.1073/pnas.0605374104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Sasaki A, Wakabayashi G, Yonei YJ. Current status of bariatric surgery in Japan and effectiveness in obesity and diabetes. J Gastroenterol. 2014;49:57–63. doi: 10.1007/s00535-013-0802-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.De Filippo C, Cavalieri D, Di Paola M, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A. 2010;107:14691–14696. doi: 10.1073/pnas.1005963107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Fujimoto T, Imaeda H, Takahashi K, et al. Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn’s disease. J Gastroenterol Hepatol. 2013;28:613–619. doi: 10.1111/jgh.12073. [DOI] [PubMed] [Google Scholar]
  • 12.Takahashi S, Tomita J, Nishioka K, Hisada T, Nishijima M. Development of a prokaryotic universal primer for simultaneous analysis of Bacteria and Archaea using next-generation sequencing. PLoS One. 2014;9:e105592. doi: 10.1371/journal.pone.0105592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Blair YI, McMahon AD, Macpherson LM. Comparison and relative utility of inequality measurements: as applied to Scotland’s child dental health. PLoS One. 2013;8:e58593. doi: 10.1371/journal.pone.0058593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007;73:5261–5267. doi: 10.1128/AEM.00062-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Nakayama J, Watanabe K, Jiang J, et al. Diversity in gut bacterial community of school-age children in Asia. Sci Rep. 2015;5:8397. doi: 10.1038/srep08397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature. 2009;457:480–484. doi: 10.1038/nature07540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Seki Y, Kakizaki S, Horiguchi N, et al. Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery J Gastroenterol 2005. DOI:10.1007/s00535-015-1114-8 [DOI] [PubMed] [Google Scholar]
  • 18.Armougom F, Henry M, Vialettes B, Raccah D, Raoult D. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients. PLoS One. 2009;4:e7125. doi: 10.1371/journal.pone.0007125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Santacruz A, Collado MC, García-Valdés L, et al. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br J Nutr. 2010;104:83–92. doi: 10.1017/S0007114510000176. [DOI] [PubMed] [Google Scholar]
  • 20.Goldsmith JR, Sartor RB. The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications. J Gastroenterol. 2014;49:785–798. doi: 10.1007/s00535-014-0953-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Taira T, Yamaguchi S, Takahashi A, et al. Dietary polyphenols increase fecal mucin and immunoglobulin A and ameliorate the disturbance in gut microbiota caused by a high fat diet. J Clin Biochem Nutr. 2015;57:212–216. doi: 10.3164/jcbn.15-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Schwiertz A, Taras D, Schäfer K, et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 2010;18:190–195. doi: 10.1038/oby.2009.167. [DOI] [PubMed] [Google Scholar]
  • 23.Duncan SH, Lobley GE, Holtrop G, et al. Human colonic microbiota associated with diet, obesity and weight loss. J Int J Obes (Lond) 2008;32:1720–1724. doi: 10.1038/ijo.2008.155. [DOI] [PubMed] [Google Scholar]
  • 24.Clarke SF, Murphy EF, Nilaweera K, et al. The gut microbiota and its relationship to diet and obesity: new insights. Gut Microbes. 2012;3:186–202. doi: 10.4161/gmic.20168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Duncan SH, Belenguer A, Holtrop G, Johnstone AM, Flint HJ, Lobley GE. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol. 2007;73:1073–1078. doi: 10.1128/AEM.02340-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Murphy EF, Cotter PD, Healy S, et al. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut. 2010;59:1635–1642. doi: 10.1136/gut.2010.215665. [DOI] [PubMed] [Google Scholar]
  • 27.Kostic AD, Gevers D, Pedamallu CS, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 2012;22:292–298. doi: 10.1101/gr.126573.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Yu J, Feng Q, Wong SH, et al. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer Gut 2015. DOI: 10.1136/gutjnl-2015-309800 [DOI] [PubMed] [Google Scholar]
  • 29.Ohkusa T, Sato N, Ogihara T, Morita K, Ogawa M, Okayasu I. Fusobacterium varium localized in the colonic mucosa of patients with ulcerative colitis stimulates species-specific antibody. J Gastroenterol Hepatol. 2002;17:849–853. doi: 10.1046/j.1440-1746.2002.02834.x. [DOI] [PubMed] [Google Scholar]
  • 30.Verdam FJ, Fuentes S, de Jonge C. Human intestinal microbiota composition is associated with local and systemic inflammation in obesity. Obesity (Silver Spring) 2013;21:E607–E615. doi: 10.1002/oby.20466. [DOI] [PubMed] [Google Scholar]
  • 31.Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A. 2008;105:16731–16736. doi: 10.1073/pnas.0804812105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Atarashi K, Tanoue T, Oshima K, et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature. 2013;500:232–236. doi: 10.1038/nature12331. [DOI] [PubMed] [Google Scholar]
  • 33.Furusawa Y, Obata Y, Fukuda S, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013;504:446–450. doi: 10.1038/nature12721. [DOI] [PubMed] [Google Scholar]
  • 34.Furet JP, Kong LC, Tap J, et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes. 2010;59:3049–3057. doi: 10.2337/db10-0253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Sheehan D, Moran C, Shanahan F. The microbiota in inflammatory bowel disease. J Gastroenterol. 2015;50:495–507. doi: 10.1007/s00535-015-1064-1. [DOI] [PubMed] [Google Scholar]
  • 36.Ramanan D, Tang MS, Bowcutt R, Loke P, Cadwell K. Bacterial sensor Nod2 prevents inflammation of the small intestine by restricting the expansion of the commensal Bacteroides vulgatus. Immunity. 2014;41:311–324. doi: 10.1016/j.immuni.2014.06.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Ignacio A, Fernandes MR, Rodrigues VA, et al. Correlation between body mass index and faecal microbiota from children Clin Microbiol Infect 2015. DOI:10.1016/j.cmi.2015.10.031 [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Biochemistry and Nutrition are provided here courtesy of The Society for Free Radical Research Japan

RESOURCES